Provided by Tiger Trade Technology Pte. Ltd.

Atrium Therapeutics

13.20
-0.2800-2.08%
Post-market: 13.200.00000.00%19:30 EDT
Volume:180.68K
Turnover:2.39M
Market Cap:225.79M
PE:-3.42
High:13.59
Open:13.53
Low:12.96
Close:13.48
52wk High:16.77
52wk Low:11.13
Shares:17.11M
Float Shares:15.72M
Volume Ratio:0.84
T/O Rate:1.15%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.8578
EPS(LYR):-3.1905
ROE:-43.98%
ROA:-399.25%
PB:1.05
PE(LYR):-4.14

Loading ...

BioNTech’s New HIV RNA Vaccine Trial: What Investors Should Watch Now

TIPRANKS
·
Yesterday

Brii Biosciences Narrows Interim Loss as HBV and RNA Pipelines Advance

TIPRANKS
·
Aug 21

Atrium Therapeutics Awards New Hire Stock Options for 11,000 Shares at $13.48 Each

Reuters
·
Aug 21

Atrium Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Aug 21

Pharma Sector Doubles Down on AI Amid Hopes of Slashing Costs, Timelines

Reuters
·
Aug 20

One Nation staffer allegedly assaulted at major Australian show‘They were spat on. They were punched.’3 min read

7NEWS
·
Aug 17

Atrium Therapeutics Price Target Maintained with a $25.00/Share by HC Wainwright & Co.

Dow Jones
·
Aug 15

The huge change set to reshape a beloved Australian traditionNew arenas, homes and facilities are coming to a historic precinct with a 150-year legacy.3 min read

7NEWS
·
Aug 15

Atrium Therapeutics, Inc. (RNA) Receives a Buy from Wells Fargo

TIPRANKS
·
Aug 14

Heart Drug Developer Atrium Therapeutics' Q2 Loss Widens as Expenses Rise

Reuters
·
Aug 14

Atrium Therapeutics Q2 Basic EPS USD -1.18

THOMSON REUTERS
·
Aug 14

Atrium Therapeutics Posts Investor Presentation on Precision RNA Medicines for Cardiac Disease

Reuters
·
Aug 14

Atrium Therapeutics Posts Q2 R&D Expense of $15.3 Million on Trial Prep, IND-Enabling Work

Reuters
·
Aug 14

Atrium Therapeutics Q2 FY26 Net Loss Widens to $20.19 Million; Revenue Falls to $3 Million

Reuters
·
Aug 14

Atrium Therapeutics Q2 EPS $(1.18) Misses $(1.01) Estimate, Sales $3.004M Beat $2.000M Estimate

Benzinga Earnings
·
Aug 14

Atrium Therapeutics, Inc. (RNA) Receives a Buy from H.C. Wainwright

TIPRANKS
·
Aug 14

Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration

THOMSON REUTERS
·
Aug 13

Atrium Therapeutics - Eligible for up to $1.35 Bln R&D Milestones, $825 Mln Commercial Milestones, Tiered Royalties

THOMSON REUTERS
·
Aug 13

Atrium Therapeutics - Bristol Myers Squibb to Fund All Future Development and Commercialization Activities

THOMSON REUTERS
·
Aug 13

CSPC Pharma (01093) Receives FDA Clearance for US Clinical Trial of Monkeypox mRNA Vaccine

Stock News
·
Aug 10